title: Who should we cool after perinatal asphyxia?
abstract: Three ongoing challenges have arisen after the introduction of therapeutic hypothermia (TH) as standard of care for term newborns with moderate or severe perinatal asphyxia: (i) to ensure that the correct group of infants are cooled; (ii) to optimize the delivery of TH and intensive care in relation to the severity of the encephalopathy; (iii) to systematically follow up the long-term efficacy of TH using comparable outcome data between centers and countries. This review addresses the entry criteria for TH, and discusses potential issues regarding patient selection, and management of TH: cooling mild, moderate, and very severe perinatal asphyxia, cooling longer or deeper, and/or starting with a greater delay. This includes cooling of patients outside of standard trial entry criteria, such as after postnatal collapse, premature infants, those with infection, and infants with metabolic, chromosomal or surgical diagnoses in addition to perinatal asphyxia.
authors: Department of Physiology, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway; Neonatal Neuroscience, School of Clinical Sciences, University of Bristol, Bristol, UK. Electronic address: marianne.thoresen@medisin.uio.no.
authors: Marianne
authors: M
authors: Thoresen
mesh_terms: D001238:Asphyxia Neonatorum / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D007036:Hypothermia, Induced / Q000379:methods*; D007231:Infant, Newborn; D007234:Infant, Premature; D018579:Patient Selection; D012720:Severity of Illness Index
keywords: Clinical trial; Follow-up; Human; Hypoxic–ischemic encephalopathy; Inclusion criteria; Therapeutic hypothermia